Bioinformatics analysis of SARS-CoV-2 infection-associated immune injury and therapeutic prediction for COVID-19
H Zhang, H Chen, J Zhang, X Chen… - … and Critical Care …, 2021 - journals.lww.com
Background: Severe acute respiratory syndrome coronavirus 2 is a highly contagious viral
infection, without any available targeted therapies. The high mortality rate of COVID-19 is …
infection, without any available targeted therapies. The high mortality rate of COVID-19 is …
Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients
This study aimed to identify significant gene expression profiles of the human lung epithelial
cells caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …
cells caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections …
Molecular modeling of C1‐inhibitor as SARS‐CoV‐2 target identified from the immune signatures of multiple tissues: An integrated bioinformatics study
K Sekaran, R Polachirakkal Varghese… - Cell Biochemistry …, 2023 - Wiley Online Library
The expeditious transmission of the severe acute respiratory coronavirus 2 (SARS‐CoV‐2),
a strain of COVID‐19, crumbled the global economic strength and caused a veritable …
a strain of COVID‐19, crumbled the global economic strength and caused a veritable …
Explanatory predictive model for COVID-19 severity risk employing machine learning, shapley addition, and LIME
The rapid spread of SARS-CoV-2 threatens global public health and impedes the operation
of healthcare systems. Several studies have been conducted to confirm SARS-CoV-2 …
of healthcare systems. Several studies have been conducted to confirm SARS-CoV-2 …
[HTML][HTML] Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis
Highly pathogenic coronaviruses (CoVs) induce acute respiratory distress syndrome, and
the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has caused a pandemic …
the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 has caused a pandemic …
[HTML][HTML] COVID-19 and lung cancer: risks, mechanisms and treatment interactions
Cases of the 2019 novel coronavirus also known as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) continue to rise worldwide. To date, there is no effective …
coronavirus 2 (SARS-CoV-2) continue to rise worldwide. To date, there is no effective …
Bioinformatics Approach Predicts Candidate Targets for SARS‐CoV‐2 Infections to COPD Patients
L Che, G Chen, X Cai, Z Xie, T Xia… - BioMed Research …, 2022 - Wiley Online Library
COVID‐19 is still prevalent in more world regions and poses a severe threat to human
health due to its high pathogenicity. The incidence of COPD patients is gradually increasing …
health due to its high pathogenicity. The incidence of COPD patients is gradually increasing …
Association of cigarette smoking, COPD, and lung cancer with expression of SARS-CoV-2 entry genes in human airway epithelial cells
SARS-CoV-2 enters into human airway epithelial cells via membrane fusion or endocytosis,
and this process is dependent on ACE2, TMPRSS2, and cathepsin L. In this study, we …
and this process is dependent on ACE2, TMPRSS2, and cathepsin L. In this study, we …
Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease, more commonly
COVID-19 has emerged as a world health pandemic. There are couples of treatment …
COVID-19 has emerged as a world health pandemic. There are couples of treatment …
COVID-19 and cytokine storm
K Mukherjee - … Journal of Bioinformatics and Biological Science, 2020 - indianjournals.com
Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes
coronavirus disease 2019 (COVID-19). As of October 31, 2020, the outbreak of COVID-19 …
coronavirus disease 2019 (COVID-19). As of October 31, 2020, the outbreak of COVID-19 …